BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23933542)

  • 1. The 9p21 locus does not affect risk of coronary artery disease through induction of type 1 interferons.
    Erridge C; Gracey J; Braund PS; Samani NJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1376-81. PubMed ID: 23933542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype.
    Almontashiri NA; Fan M; Cheng BL; Chen HH; Roberts R; Stewart AF
    J Am Coll Cardiol; 2013 Jan; 61(2):143-7. PubMed ID: 23199516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH; Ling P; Liu MF
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent association of the variant rs1333049 at the 9p21 locus and coronary heart disease.
    Mendonça I; dos Reis RP; Pereira A; Café H; Serrão M; Sousa AC; Freitas AI; Guerra G; Freitas S; Freitas C; Ornelas I; Brehm A; Araújo JJ
    Rev Port Cardiol; 2011 Jun; 30(6):575-91. PubMed ID: 21874923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphism.
    Aschauer S; Mittermayer F; Wagner CC; Schmidt WM; Brunner M; Haslacher H; Wolzt M; Müller M
    Eur J Clin Invest; 2010 Aug; 40(8):700-5. PubMed ID: 20649639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease.
    Dandona S; Stewart AF; Chen L; Williams K; So D; O'Brien E; Glover C; Lemay M; Assogba O; Vo L; Wang YQ; Labinaz M; Wells GA; McPherson R; Roberts R
    J Am Coll Cardiol; 2010 Aug; 56(6):479-86. PubMed ID: 20670758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9p21.3 coronary artery disease risk locus and interferon alpha 21: Association study in an Asian Indian population.
    Kalpana B; Murthy DK; Balakrishna N
    Indian Heart J; 2019; 71(6):476-480. PubMed ID: 32248921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9p21.3 Coronary Artery Disease Risk Variants Disrupt TEAD Transcription Factor-Dependent Transforming Growth Factor β Regulation of p16 Expression in Human Aortic Smooth Muscle Cells.
    Almontashiri NA; Antoine D; Zhou X; Vilmundarson RO; Zhang SX; Hao KN; Chen HH; Stewart AF
    Circulation; 2015 Nov; 132(21):1969-78. PubMed ID: 26487755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus.
    Jarinova O; Stewart AF; Roberts R; Wells G; Lau P; Naing T; Buerki C; McLean BW; Cook RC; Parker JS; McPherson R
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1671-7. PubMed ID: 19592466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common SNP-based haplotype analysis of the 9p21.3 gene locus as predictor coronary artery disease in Tanzanian population.
    Akan G; Kisenge P; Sanga TS; Mbugi E; Adolf I; Turkcan MK; Janabi M; Atalar F
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):33-43. PubMed ID: 31472045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of association between common genetic variants on chromosome 9p21 and coronary artery disease in Turkish population.
    Çakmak HA; Bayoğlu B; Durmaz E; Can G; Karadağ B; Cengiz M; Vural VA; Yüksel H
    Anatol J Cardiol; 2015 Mar; 15(3):196-203. PubMed ID: 25333979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis.
    Chan K; Patel RS; Newcombe P; Nelson CP; Qasim A; Epstein SE; Burnett S; Vaccarino VL; Zafari AM; Shah SH; Anderson JL; Carlquist JF; Hartiala J; Allayee H; Hinohara K; Lee BS; Erl A; Ellis KL; Goel A; Schaefer AS; El Mokhtari NE; Goldstein BA; Hlatky MA; Go AS; Shen GQ; Gong Y; Pepine C; Laxton RC; Whittaker JC; Tang WH; Johnson JA; Wang QK; Assimes TL; Nöthlings U; Farrall M; Watkins H; Richards AM; Cameron VA; Muendlein A; Drexel H; Koch W; Park JE; Kimura A; Shen WF; Simpson IA; Hazen SL; Horne BD; Hauser ER; Quyyumi AA; Reilly MP; Samani NJ; Ye S
    J Am Coll Cardiol; 2013 Mar; 61(9):957-70. PubMed ID: 23352782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the coronary artery disease risk locus on chromosome 9p21.3 and abdominal aortic aneurysm.
    Bown MJ; Braund PS; Thompson J; London NJ; Samani NJ; Sayers RD
    Circ Cardiovasc Genet; 2008 Oct; 1(1):39-42. PubMed ID: 20031540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism on chromosome 9p21.3 contributes to early-onset and severity of coronary artery disease in non-diabetic and type 2 diabetic patients.
    Wang W; Peng WH; Lu L; Zhang RY; Zhang Q; Wang LJ; Chen QJ; Shen WF
    Chin Med J (Engl); 2011 Jan; 124(1):66-71. PubMed ID: 21362310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants of chromosome 9p21.3 region associated with coronary artery disease and premature coronary artery disease in an Asian Indian population.
    Kalpana B; Murthy DK; Balakrishna N; Aiyengar MT
    Indian Heart J; 2019; 71(3):263-271. PubMed ID: 31543200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant on 9p21 is strongly associated with coronary artery disease but lacks association with myocardial infarction and disease severity in a population in Western India.
    Bhanushali AA; Parmar N; Contractor A; Shah VT; Das BR
    Arch Med Res; 2011 Aug; 42(6):469-74. PubMed ID: 21925557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the association of genetic variants on the chromosomal loci 9p21.3, 6q25.1, and 2q36.3 with angiographically characterized coronary artery disease.
    Muendlein A; Saely CH; Rhomberg S; Sonderegger G; Loacker S; Rein P; Beer S; Vonbank A; Winder T; Drexel H
    Atherosclerosis; 2009 Jul; 205(1):174-80. PubMed ID: 19135198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.
    Harismendy O; Notani D; Song X; Rahim NG; Tanasa B; Heintzman N; Ren B; Fu XD; Topol EJ; Rosenfeld MG; Frazer KA
    Nature; 2011 Feb; 470(7333):264-8. PubMed ID: 21307941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-associated polymorphisms in 9p21 are not associated with extreme longevity.
    Congrains A; Kamide K; Hirose N; Arai Y; Oguro R; Nakama C; Imaizumi Y; Kawai T; Kusunoki H; Yamamoto H; Onishi-Takeya M; Takeya Y; Yamamoto K; Sugimoto K; Akasaka H; Saitoh S; Miura T; Awata N; Kato N; Katsuya T; Ikebe K; Gondo Y; Rakugi H
    Geriatr Gerontol Int; 2015 Jun; 15(6):797-803. PubMed ID: 25257646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of leukocyte type-I interferon production and risk of coronary artery disease.
    Nelson CP; Schunkert H; Samani NJ; Erridge C
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1456-62. PubMed ID: 25882064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.